Koltsov, Egor – Trademark Portfolio
Entity Type: 01
Koltsov, Egor owns a portfolio of 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as L'S, DR.G, ELLZ, I WON, and DR.GANJA. Of these, 20 are registered and 2 are pending. The portfolio spans 8 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 25 (Clothing). Headquartered in Beverly Hills, CA.
9190 W. Olympic Blvd.
Beverly Hills, CA 90212
Showing of trademarks Trademarks
Trademark Classifications
Koltsov, Egor's trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Insurance; financial affairs; monetary affairs; real estate affairs
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Koltsov, Egor have?
Koltsov, Egor has 33 U.S. trademarks filed with the USPTO. Of these, 20 registered, 2 pending, 10 abandoned, 1 cancelled.
What trademark classes does Koltsov, Egor file in?
Koltsov, Egor files trademarks across 8 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 25 (Clothing), Class 34 (Smokers Articles), Class 16 (Paper Goods), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Koltsov, Egor's most well-known trademarks?
Koltsov, Egor's registered trademark portfolio includes well-known marks such as L'S, DR.G, ELLZ, I WON, and DR.GANJA. These are among 20 currently registered trademarks in the portfolio.
What is Koltsov, Egor's trademark registration success rate?
Koltsov, Egor has a 65% trademark registration rate, with 20 out of 31 resolved applications resulting in successful registration. Currently, 2 applications are pending review.